What is true regarding the frequency of performing accuracy/precision testing on ACDs?

The correct response is rooted in the guidelines established for maintaining the quality and reliability of automated compounding devices (ACDs) in sterile compounding settings. Performing accuracy and precision testing once a month aligns with the recommendations that emphasize the need for regular checks to ensure that the devices are functioning correctly and accurately delivering the correct dosages. This frequency strikes a balance between ensuring operational integrity and not being overly burdensome on resources and staff.

Monthly testing helps to confirm that the compounding processes remain reliable over time, as variations can occur due to equipment wear or changes in material behavior. Regular testing fosters an environment of ongoing compliance with safety standards and helps identify any deviations early, preventing potential errors in patient care.

Testing daily may be excessive, as consistent performance of most well-maintained devices across short intervals is generally expected. Annual testing would be insufficient, as it may allow significant deviations to go undetected for extended periods, potentially endangering patient safety. Testing once a month provides a safeguard while remaining practical for operational demands.